
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
FDA-approved safety device reduces needlestick injuries: Columbus, OH-The FDA-approved NeedleZap, a safety device that disintegrates the sharp portion of a hypodermic needle to help reduce accidental needlestick injuries, is now available from E Med Future, Inc.





